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 ABSTRACT |	 Ameloblastic	fibroma	is	a	rare	benign	odontogenic	tumor	in	which	both	epithelial	and	ectomesenchymal	components	
are	neoplastic.	A	 24-year-old	male	 patient	was	 referred	 to	 the	 Stomatology	Department	with	difficulty	 to	 chew	and	
swelling	in	the	right	posterior	region	of	the	mandible.	The	panoramic	radiograph	showed	a	well-circumscribed,	uni-
locular	radiolucent	 lesion	with	partially	radiopaque	borders	 involving	first	and	second	unerupted	molars.	Computed	
tomography	imaging	presented	a	hypodense	image	with	well-delimited	isodense	content,	bulging	and	rupture	of	corti-
cal	bones.	The	patient	underwent	an	incisional	biopsy.	Microscopically,	the	lesion	was	composed	of	many	mesenchymal	
tissue	cells	in	strand	form,	arranged	in	cords,	islands	and	nests	of	odontogenic	epithelium;	the	diagnostic	was	amelo-
blastic	fibroma.	The	patient	was	referred	to	the	hospital	for	enucleation	and	curettage	of	the	lesion	and	extraction	of	
the	associated	teeth.	After	8	months	of	follow-up,	no	recurrence	was	observed.	This	case	emphasizes	the	importance	of	
differential	diagnosis,	anatomopathological	exam,	and	both	clinical	and	imaging	follow-up,	since	this	kind	of	tumor	can	
recur	and	progress	to	malignancy.
 DESCRIPTORS |	 Odontogenic	Tumors;	Oral	Pathology;	Ameloblastic	Fibroma.
 RESUMO | Fibroma ameloblástico: um estudo de caso •	O	fibroma	ameloblástico	é	um	tumor	odontogênico	benigno	raro	no	qual	os	compo-
nentes	epiteliais	e	ectomesenquimais	são	neoplásicos.	Paciente	de	24	anos	de	idade	foi	encaminhado	à	clínica	de	Estomatologia	devido	
à	dificuldade	de	mastigar	e	edema	na	região	posterior	direita	da	mandíbula.	A	radiografia	panorâmica	evidenciou	uma	lesão	radiolúcida	
unilocular,	circunscrita,	com	bordas	parcialmente	radiopacas	envolvendo	o	primeiro	e	segundo	molar	não	 irrompidos.	A	tomografia	
computadorizada	apresentou	 imagem	hipodensa,	com	conteúdo	 isodenso,	bem	delimitada,	com	abaulamento	e	rompimento	das	cor-
ticais	ósseas.	O	paciente	foi	submetido	a	uma	biópsia	incisional.	Microscopicamente,	a	lesão	foi	composta	por	tecido	mesenquimal	rico	
em	células,	formando	cordões,	ilhas	e	ninhos	de	epitélio	odontogênico,	cujo	diagnóstico	foi	de	fibroma	ameloblástico.	O	paciente	foi	en-
caminhado	ao	hospital	para	enucleação	e	curetagem	da	lesão	com	extração	dos	dentes	associados.	Após	8	meses	de	acompanhamento,	
não	 se	 observou	 recorrência.	Este	 caso	 enfatiza	 a	 importância	do	diagnóstico	diferencial,	 exame	anatomopatológico,	 e	 acompanha-
mento	clínico	e	radiográfico,	uma	vez	que	este	tumor	pode	recidivar	e	evoluir	para	malignidade.
 DESCRITORES |	 Tumores	Odontogênicos;	Patologia	Oral;	Fibroma	Ameloblástico.
 CORRESPONDING AUTHOR | • Juliane Piragine Araujo Department  of  Radiology,  School  of  Dentistry,  University  of 
São  Paulo  • Av. Professor Lineu Prestes, 2227, Cidade Universitária São  Paulo,  SP, 
Brazil  • 05508-000 Email: jupiragine@usp.br
• Received Aug 20, 2015  • Accepted Oct 13, 2015
• DOI http://dx.doi.org/10.11606/issn.2357-8041.clrd.2015.12951
251
Ameloblastic fibroma: a case report
252 ● Clin Lab Res Den 2015; 21 (4): 251-257
INTRODUCTION
Ameloblastic	 fibroma	 (AF)	 is	 a	 rare	 benign	
odontogenic	tumor,	originating	from	the	odontoge-
nic	epithelium	and	odontogenic	mesenchyme,1	and	
it	is	classified	as	a	true	mixed	tumor.2
According	 to	 Barnes	 et	 al.,2	 mixed	 odontoge-
nic	 tumors	 include:	 ameloblastic	 fibrodentinoma	
(AFD),	 ameloblastic	 fibro-odontoma	 (AFO),	 odon-
toma	complex	and	compound,	odontoameloblasto-
ma,	 calcifying	 cystic	 odontogenic	 tumor,	 dentino-
genic	 ghost	 cell	 tumor,	 and	 ameloblastic	 fibroma.	
To	 some	 authors,	 mixed	 odontogenic	 tumors	 are	
different	developmental	stages	of	the	same	lesion.1
The	incidence	of	odontogenic	tumors	in	a	study	
by	Nalabolu	 et	 al.	was	 2.17%	of	 a	 total	 7,400	oral	
biopsies.	The	AF	corresponded	to	0.6%	of	all	odon-
togenic	tumors.3	The	mean	age	was	14.8	years	(ran-
ging	 from	 7	weeks	 to	 62	 years).2	 AF	 occurs	more	
frequently	in	the	mandible	and	the	posterior	region	
is	more	affected	than	the	anterior	region.1,4
Clinical	 and	 radiographic	 features	 of	 odonto-
genic	 tumors,	 as	 well	 as	 their	 prognosis	 and	ma-
lignant	 transformation	 are	 conflicting.1	 The	 ra-
diographic	 features	 include	 well-defined,	 uni-	 or	
multilocular	radiolucency,	and,	in	most	cases,	a	ra-
diopaque	boundary.2,4
This	 case	 report	 describes	 the	 case	 of	 a	 young	
man	 affected	 by	 mandibular	 AF,	 associated	 with	
first	and	second	molars	on	the	right	side.
CASE REPORT
A	 24-year	 old	 male	 was	 referred	 to	 the	
Stomatology	Department	of	the	School	of	Dentistry,	
University	 of	 São	 Paulo,	 complaining	 of	 difficulty	
chewing	and	a	progressive,	asymptomatic	increase	
in	the	size	of	his	right	mandible,	which	he	noticed	
about	15	days	before	examination.	The	patient	had	
no	relevant	medical	history.
Extraoral	 examination	 revealed	 facial	 asym-
metry,	bulging	of	the	right	 lower	third	of	the	face,	
intact	 skin,	 no	 palpable	 lymphonodes,	 and	 no	
paresthesia.	
The	 intraoral	 examination	 revealed	a	 tumor	 in	
the	right	mandible,	with	an	ulcerated	surface,	a	re-
ddish	 color,	 well-defined	 borders,	 and	 measuring	
approximately	3	cm.	Absence	of	the	second	premo-
lar	and	the	first	and	second	molars	was	noted	in	the	
region	of	the	tumor.
Figure 1 | Extraoral examination revealed facial asymmetry with bulging of the lower third 
of the face and intact skin, on the right side.
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A	 panoramic	 radiograph	 (PR)	 revealed	 a	 uni-
locular,	 radiolucent	 lesion	with	a	partially	defined	
radiopaque	 boundary,	 associated	 to	 non-erupted	
first	and	second	molars	displaced	towards	the	base	
of	the	mandible.	Helicoidal	computed	tomography	
(HCT)	 soft	 window	 image	 revealed	 a	 hypodense	
image	with	 isodense	content,	and	cortical	bulging	
with	rupture	of	alveolar	crest.	
Figure 2 | A,B: An ulcerated tumor due to chewing, affecting the posterior right mandible and causing 
expansion of the cortical bone.
Figure 3 | A: A panoramic  radiograph shows a well-delimited  radiolucent  lesion with partially  ra-
diopaque borders. B, C: HCT coronal and axial view of tissues shows a well-delimited, unilocular, hy-
podense lesion with isodense content, with cortical expansion and rupture, affecting the posterior right 
mandible.
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INVESTIGATION, HISTOPATHOLOGY 
AND TREATMENT
The	patient	was	submitted	to	an	incisional	biop-
sy	under	 local	anesthesia,	and	the	 tissue	was	sent	
for	histopathological	analysis.	Microscopically,	the	
tumor	consisted	of	odontogenic	epithelium	lying	in	
mesenchymal	 tissue	 resembling	 embryonic	 tooth	
pulp.	The	odontogenic	epithelium	consisted	of	short	
and	long	narrow	cords	or	islands,	usually	two	cells	
thick,	with	 cuboidal	 or	 columnar	 cells	 sometimes	
in	 anastomosing	 arrangement.	 The	 final	 histopa-
thological	diagnosis	was	ameloblastic	fibroma.	
Therefore,	 surgery	 was	 indicated	 and	 perfor-
med	 under	 general	 anesthesia,	 with	 curettage	 of	
the	lesion	and	tooth	extraction	(Figure	5).	AF	diag-
nosis	was	confirmed.	A	helicoidal	tomography	was	
performed	8	months	after	surgery	(Figure	6).	The	
patient	 has	 been	 followed-up	with	 no	 evidence	 of	
recurrence,	and	has	been	asymptomatic	ever	since	
(Figure	7).
Figure 4 | Benign neoplasm consisting of mesenchymal tissue asso-
ciated with odontogenic epithelium arranged in short and long, narrow 
cords or islands (H&E 200x).
Figure 5 | A-C: Trans-surgical 
procedure:  enucleation  with  cu-
rettage  of  the  surrounding  bone 
and  removal  of  the  affected 
tooth. D: An extracted specimen.
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Figure 6 |  A:  Five  months  after  surgery,  the  patient  presented  symmetry. 
B, C: Intraoral examination revealed normal alveolar ridge and intact surface.
Figure 7 | A, B: HCT coronal view shows an area of bone defect from surgery, 
with no evidence of lesion. C, D: HCT axial view shows a hyperdense area, sug-
gesting a process of bone repair in the right mandible.
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DISCUSSION
Ameloblastic	fibroma	of	the	jaw	is	a	benign,	rela-
tively	rare,	mixed	odontogenic	tumor,	whose	epithe-
lial	and	mesenchymal	components	are	neoplastic.2,4 
This	tumor	is	usually	diagnosed	in	the	first	and	se-
cond	 decades	 of	 life	 (72.4%),	 when	 odontogenesis	
is	complete	 (80%	of	cases),	and	affects	mainly	 the	
mandible.1,4	In	 this	 case,	 the	 lesion	was	diagnosed	
in	the	third	decade	of	life,	and	occurred	in	the	pos-
terior	region	of	the	mandible.	However,	some	cases	
of	AF	in	the	maxilla	have	also	been	reported.1,5
AF	 does	 not	 have	 a	 specific	 sign	 or	 symptom,	
and	it	is	often	observed	in	a	routine	radiograph,	in	
the	form	of	cysts	and	other	odontogenic	tumors.2	In	
this	 case,	 the	 patient	 never	 complained	 about	 the	
absence	 of	 his	 right	 lower	molars.	His	 chief	 com-
plaint	was	 just	difficulty	 chewing	due	 to	 the	 large	
mass	of	tissue	in	this	region.
Most	 cases	 of	 AF	 present	 painless	 swelling,	 or	
are	 discovered	due	 to	 disturbances	 of	 tooth	 erup-
tion.	Radiographically,	 the	 tumor	 presents	 a	well-	
demarcated	 radiolucency,	 often	 associated	 with	 a	
malpositioned	 tooth.2	 In	 addition,	 a	 multilocular	
pattern	 often	 characterizes	 larger	 tumors	 (75%	 of	
the	cases),	and	a	unilocular	pattern	is	more	common	
in	 smaller	 lesions	 (up	 to	 4	 cm),6	 as	was	 this	 case.	
Differential	diagnosis	of	AF	lesions	must	be	made,	
distinguishing	ameloblastoma,	odontogenic	myxo-
ma,	 dentigerous	 cysts,	 odontogenic	 keratocysts,	
central	giant	cell	granuloma,	and	histocytosis.7
Histological	 examination	 of	 AF	 showed	 stran-
ds,	 cords,	 and	 islands	 of	 odontogenic	 epithelium	
in	 a	 primitive	 connective	 tissue	 stroma	 close-
ly	 resembling	 the	 dental	 papilla.	 No	 hard	 tooth	
structures	 were	 detected	 in	 any	 of	 the	 primary	
tumors.4	 Tumors	 with	 AF	 histomorphology	 may	
form	dysplastic	 dentin;	 in	 this	 case,	 they	 are	 cal-
led	 ameloblastic	 fibrodentinoma.2	 Some	 authors	
state	that	AF	is	a	separate,	specific	neoplastic	enti-
ty	that	does	not	develop	into	a	more	differentiated	
odontogenic	tumor.2
Another	 study	 asserts	 that	 there	 are	 two	 va-
riants	of	 ameloblastic	fibroma:	neoplastic	 and	ha-
martomatous.	 Lesions	 in	 patients	 aged	 >22	 years	
are	considered	 true	neoplasms,	whereas	 those	oc-
curring	in	younger	patients	may	be	either	true	neo-
plasms	or	odontomas.	Asymptomatic,	small	unilo-
cular	lesions	with	no	or	minimal	bone	expansion	in	
young	individuals	are	likely	to	be	developing	odon-
tomas,	whereas	large,	expansive	lesions	with	bone	
destruction	are	neoplasms.	Since	the	histopatholo-
gy	of	 these	 two	variants	 is	 indistinguishable,	 they	
may	 be	 distinguished	 by	 clinical	 and	 radiological	
features.1 It	is	important	to	emphasize	that	this	case	
was	classified	as	a	neoplasm.
The	ectomesenchymal	component	of	AF	presents	
relatively	scanty	stellate	reticulum	in	smaller	 folli-
cles,	 compared	 to	ameloblastoma.	These	histologi-
cal	characteristics	help	distinguish	the	pathologies.7
AF	 may	 rarely	 present	 ghost	 cell	 differentia-
tion	 and	 calcification	 in	 the	 epithelial	 component.	
Recently,	 a	 study	 addressing	 an	 association	 be-
tween	 AF	 and	 calcifying	 odontogenic	 cyst	 (COC)	
with	 ghost	 cell	 differentiation	 was	 published.	
Interestingly,	all	cases	of	COC	with	ghost	cell	diffe-
rentiation	were	observed	in	the	epithelial	lining.	AF	
components	existed	in	the	cystic	wall	and	some	so-
lid	areas.	Luo	et	al.	described	a	case	of	AF	that	had	
ghost	cell	differentiation	and	calcifications	in	some	
of	the	neoplastic	epithelial	islands,	but	did	not	pre-
sent	 any	histological	 characteristics	of	COC	 in	 the	
cystic	wall.	Most	lesions	were	cystic-solid,	compri-
sed	of	 odontogenic	 epithelial	 strands,	 islands,	 and	
ectomesenchymal	myxoid	component.	The	behavior	
of	ghost	cell	differentiation	in	AF	remains	unclear.8
The	epithelial	component	of	AF	consists	of	bran-
ching	and	anastomosing	epithelial	strands	of	diffe-
rent	size,	which	form	knots.	Mitotic	figures	both	in	
epithelial	 and	mesenchymal	 components	may	 oc-
cur;	if	present,	they	should	raise	concern	about	the	
benign	nature	of	the	case.8	AF	may	rarely	progress	
to	malignancy	(ameloblastic	fibrosarcoma	–	AFS). 
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In	 this	case,	AFS	presents	a	benign	epithelial	and	
a	 malignant	 ectomesenchymal	 component.2,9	 An	
overexpression	of	Ki-67	immunoexpression	(a	pro-
liferative	nuclear	cell	marker)	and	Bcl-2	proteins	in	
AFS,	in	association	with	histopathological	features,	
may	be	useful	markers	to	identify	malignancy.9
Regarding	the	nature	and	biological	behavior	of	
tumors,	 the	 treatment	 for	AF	 in	90%	of	 the	 cases	
initially	 consists	of	 a	 conservative	 surgical	 appro-
ach,	and	in	10%	of	the	cases,	radical	surgery.4	The	
most	appropriate	treatment	for	AF	is	still	unclear.	
In	 this	 case,	 a	 conservative	 technique	was	propo-
sed,	 especially	 because	 the	 patient	 was	 young,	 as	
corroborated	by	the	literature.	The	patient’s	follow-
-up	time	is	short	to	detect	recurrences,	however,	a	
regular	follow-up	is	maintained.
CONCLUSION
Although	rare,	ameloblastic	fibroma	may	recur	
and	 progress	 to	malignancy.	 The	 objective	 of	 this	
case	report	was	to	highlight	the	challenge	involved	
in	its	correct	diagnosis	and	treatment,	considering	
AF	lesion	behavior,	and	emphasizes	the	importan-
ce	 of	 clinical	 and	 radiographic	 follow-up,	 which	
should	 be	 for	 long	 periods	 for	 early	 detection	 of	
possible	recurrences.
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